Thymic carcinoma with overexpression of mutated KIT and the response to imatinib

MeSH terms

• Antineoplastic Agents / therapeutic use*
• Benzamides
• Bone Neoplasms / secondary
• Disease Progression
• Fatal Outcome
• Gene Expression Regulation, Neoplastic*
• Humans
• Imatinib Mesylate
• Liver Neoplasms / secondary
• Male
• Mediastinal Neoplasms / secondary
• Middle Aged
• Piperazines / therapeutic use*
• Proto-Oncogene Proteins c-kit / genetics*
• Pyrimidines / therapeutic use*
• Sequence Analysis, DNA
• Sequence Deletion
• Thymoma / drug therapy
• Thymoma / genetics*
• Thymoma / pathology
• Thymus Neoplasms / drug therapy
• Thymus Neoplasms / genetics*
• Thymus Neoplasms / pathology